Literature DB >> 12761632

Autonomic dysfunctions in idiopathic Parkinson's disease.

Wolfgang H Jost1.   

Abstract

Most patients with Parkinson's disease experience autonomic dysfunction at some point in the course of their disease. In contrast to autonomic dysregulation in multisystem atrophy, they are less severe, and they frequently cause troublesome symptoms only in advanced stages of the disease. The quality of life is nevertheless substantially restricted. Cardiovascular, gastrointestinal and urogenital autonomic dysfunction is predominant. Appropriate diagnosis and treatment can greatly benefit the patient. An interdisciplinary approach is desirable in most cases.

Entities:  

Mesh:

Year:  2003        PMID: 12761632     DOI: 10.1007/s00415-003-1105-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

2.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

3.  Determinants of autonomic dysfunction in idiopathic Parkinson's disease.

Authors:  Alexei Korchounov; Kirn R Kessler; Nikolay N Yakhno; Igor V Damulin; Hayo I Schipper
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

4.  Relationships between clinical characteristics and nocturnal cardiac autonomic activity in Parkinson's disease.

Authors:  Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jeanne Maglione; Loki Natarajan; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Laura S Redwine; Sonia Ancoli-Israel
Journal:  Auton Neurosci       Date:  2012-11-08       Impact factor: 3.145

Review 5.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Gerd Fuchs; Wolfgang Greulich; Heinz Reichmann; Michael Schwarz; Birgit Herting
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

Review 6.  Sleep-disordered breathing in neurodegenerative diseases.

Authors:  Carles Gaig; Alex Iranzo
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

7.  Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease.

Authors:  Janne Ludwig; Piet Remien; Christoph Guballa; Andreas Binder; Sabine Binder; Jörn Schattschneider; Jan Herzog; Jens Volkmann; Günther Deuschl; Gunnar Wasner; Ralf Baron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

8.  Erectile function and risk of Parkinson's disease.

Authors:  Xiang Gao; Honglei Chen; Michael A Schwarzschild; Dale B Glasser; Giancarlo Logroscino; Eric B Rimm; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2007-09-17       Impact factor: 4.897

9.  Walking economy in people with Parkinson's disease.

Authors:  Cory L Christiansen; Margaret L Schenkman; Kim McFann; Pamela Wolfe; Wendy M Kohrt
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

10.  Subtle cardiovascular dysfunction in the unilateral 6-hydroxydopamine-lesioned rat.

Authors:  K Slack; R Billing; S Matthews; H N Allbutt; R Einstein; J M Henderson
Journal:  Parkinsons Dis       Date:  2010-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.